Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Osteoporosis
Are there any concerns with using denosumab in a patient with chronic hepatitis B infection on antiviral therapy?
Related Questions
Is there a maximum duration for raloxifene use?
Is it safe to combine Prolia with other immunosuppressants?
How do you manage hepatotoxicity thought to be related to Romosozumab use?
How should we interpret DXA scans in patients with Ankylosing Spondylitis who have ankylosis of the spine?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you approach a patient with high titer ANA and a new diagnosis of ITP, but no other signs or symptoms suggestive of active rheumatologic disease?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
Would you use anabolic agents (romosozumab or PTH analogues) for osteoporosis treatment in patients with CKD?
